ZhuZhou QianJin Pharmaceutical Co Ltd (600479) — Cash Flow-to-Debt Ratio
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Cash Flow-to-Debt Ratio of 0.17x as of September 2025, meaning its operating cash flow of CN¥288.83 Million could theoretically repay 0% of its total liabilities (CN¥1.66 Billion) in one year. Explore 600479 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ZhuZhou QianJin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for ZhuZhou QianJin Pharmaceutical Co Ltd across 24 annual periods. Also explore how large is ZhuZhou QianJin Pharmaceutical Co Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Year-by-year debt coverage analysis for ZhuZhou QianJin Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see ZhuZhou QianJin Pharmaceutical Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | CN¥480.24 Million | CN¥1.61 Billion | ▲ +5.8% |
| 2024 | 0.28x | CN¥398.77 Million | CN¥1.42 Billion | ▲ +4.8% |
| 2023 | 0.27x | CN¥443.12 Million | CN¥1.65 Billion | ▼ -33.5% |
| 2022 | 0.40x | CN¥733.47 Million | CN¥1.82 Billion | ▲ +13.1% |
| 2021 | 0.36x | CN¥485.57 Million | CN¥1.36 Billion | ▼ -3.5% |
| 2020 | 0.37x | CN¥542.37 Million | CN¥1.47 Billion | ▲ +181.2% |
| 2019 | 0.13x | CN¥155.49 Million | CN¥1.18 Billion | ▼ -64.3% |
| 2018 | 0.37x | CN¥383.47 Million | CN¥1.04 Billion | ▲ +35.7% |
| 2017 | 0.27x | CN¥283.47 Million | CN¥1.05 Billion | ▲ +82.5% |
| 2016 | 0.15x | CN¥140.88 Million | CN¥948.21 Million | ▲ +71.5% |
| 2015 | 0.09x | CN¥67.48 Million | CN¥779.17 Million | ▼ -60.2% |
| 2014 | 0.22x | CN¥183.34 Million | CN¥843.20 Million | ▲ +8.0% |
| 2013 | 0.20x | CN¥137.63 Million | CN¥683.92 Million | ▼ -40.9% |
| 2012 | 0.34x | CN¥197.82 Million | CN¥581.18 Million | ▲ +334.3% |
| 2011 | 0.08x | CN¥22.58 Million | CN¥288.10 Million | ▼ -62.2% |
| 2010 | 0.21x | CN¥39.13 Million | CN¥188.65 Million | ▼ -11.3% |
| 2009 | 0.23x | CN¥73.54 Million | CN¥314.48 Million | ▲ +15.4% |
| 2008 | 0.20x | CN¥37.20 Million | CN¥183.66 Million | ▼ -51.6% |
| 2007 | 0.42x | CN¥79.26 Million | CN¥189.30 Million | ▼ -41.0% |
| 2006 | 0.71x | CN¥120.12 Million | CN¥169.13 Million | ▲ +88.8% |
| 2005 | 0.38x | CN¥76.50 Million | CN¥203.38 Million | ▲ +202.4% |
| 2004 | 0.12x | CN¥18.45 Million | CN¥148.38 Million | ▼ -54.1% |
| 2003 | 0.27x | CN¥50.96 Million | CN¥188.23 Million | ▲ +676.9% |
| 2002 | 0.03x | CN¥6.07 Million | CN¥174.31 Million | — |